Acute dopamine D1 and D2 receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects (original) (raw)
Ahveninen J, Kahkonen S, Pennanen S, Liesivuori J, Ilmoniemi RJ, Jaaskelainen IP (2002) Tryptophan depletion effects on EEG and MEG responses suggest serotonergic modulation of auditory involuntary attention in humans. Neuroimage 16:1052–1061 ArticlePubMed Google Scholar
Baker K, Baldeweg T, Sivagnanasundaram S, Scambler P, Skuse D (2005) COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry 58:23–31 ArticlePubMedCAS Google Scholar
Baldeweg T, Klugman A, Gruzelier JH, Hirsch SR (2002) Impairment in frontal but not temporal components of mismatch negativity in schizophrenia. Int J Psychophysiol 43:111–122 ArticlePubMed Google Scholar
Baldeweg T, Klugman A, Gruzelier J, Hirsch SR (2004) Mismatch negativity potentials and cognitive impairment in schizophrenia. Schizophr Res 69:203–217 ArticlePubMed Google Scholar
Baldeweg T, Wong D, Stephan KE (2006) Nicotinic modulation of human auditory sensory memory: Evidence from mismatch negativity potentials. Int J Psychophysiol 59:49–58 ArticlePubMed Google Scholar
Bartholomeusz CF, Box G, Van Rooy C, Nathan PJ (2003) The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans. J Psychopharmacol 17:9–15 ArticlePubMedCAS Google Scholar
Bramon E, Croft RJ, McDonald C, Virdi GK, Gruzelier JG, Baldeweg T, Sham PC, Frangou S, Murray RM (2004) Mismatch negativity in schizophrenia: a family study. Schizophr Res 67:1–10 ArticlePubMed Google Scholar
Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D (1998) Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29:142–147 ArticlePubMedCAS Google Scholar
Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87–96 ArticlePubMedCAS Google Scholar
Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson’s disease. Trends Neurosci 13:272–276 ArticlePubMedCAS Google Scholar
Checkley SA (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med 10:35–53 ArticlePubMedCAS Google Scholar
Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatryyiatr 148:1474–1486 CAS Google Scholar
Drago F, Scapagnini U (1986) Hormonal modulation of central dopaminergic transmission. J Neural Transm, Suppl 22:47–54 CAS Google Scholar
Ellis KA, Nathan PJ (2001) The pharmacology of human working memory. Int J Neuropsychopharmacol 4:299–313 ArticlePubMedCAS Google Scholar
Frodl-Bauch T, Kathmann N, Möller H-J, Hegerl U (1997) Dipole localization and test-restest reliability of frequency and duration mismatch negativity generator processes. Brain Topogr 10:3–8 ArticlePubMedCAS Google Scholar
Giard M-H, Lavikainen J, Reinikainen K, Perrin F, Bertrand O, Pernier J, Näätänen R (1995) Separate representation of stimulus frequency, intensity and duration in auditory sensory memory: an event-related potential and dipole-model analysis. J Cogn Neurosci 7:133–143 Google Scholar
Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?. Schizophr Bull 26:119–136 PubMedCAS Google Scholar
Inami R, Kirino E, Inoue R, Arai H (2005) Transdermal nicotine administration enhances automatic auditory processing reflected by mismatch negativity. Pharmacol Biochem Behav 80:453–461 ArticlePubMedCAS Google Scholar
Javitt DC (2004) Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 9:984–997, 979 ArticlePubMedCAS Google Scholar
Javitt DC, Doneshka P, Zylberman I, Ritter W, Vaughan HG Jr (1993) Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study. Biol Psychiatry 33:513–519 ArticlePubMedCAS Google Scholar
Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC (1996) Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA 93:11962–11967 ArticlePubMedCAS Google Scholar
Kähkönen S, Ahveninen J, Jaaskelainen IP, Kaakkola S, Naatanen R, Huttunen J, Pekkonen E (2001) Effects of haloperidol on selective attention: a combined whole-head MEG and high-resolution EEG study. Neuropsychopharmacology 25:498–504 ArticlePubMed Google Scholar
Kähkönen S, Ahveninen J, Pekkonen E, Kaakkola S, Huttunen J, Ilmoniemi RJ, Jääskeläinen IP (2002) Dopamine modulates involuntary attention shifting and reorienting: an electromagnetic study. Clin Neurophysiol 113:1894–1902 ArticlePubMed Google Scholar
Kähkönen S, Makinen V, Jaaskelainen IP, Pennanen S, Liesivuori J, Ahveninen J (2005) Serotonergic modulation of mismatch negativity. Psychiatry Res 138:61–74 ArticlePubMedCAS Google Scholar
Kapur S, Seeman P (2002) NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry 7:837–844 ArticlePubMedCAS Google Scholar
Kathmann N, Frodl-Bauch T, Hegerl U (1999) Stability of the mismatch negativity under different stimulus and attention conditions. Clin Neurophysiol 110:317–323 ArticlePubMedCAS Google Scholar
Knott V, Blais C, Scherling C, Camarda J, Millar A, Fisher D, McIntosh J (2006a) Neural effects of nicotine during auditory selective attention in smokers: an event-related potential study. Neuropsychobiology 53:115–126 ArticlePubMedCAS Google Scholar
Knott VJ, Scherling CS, Blais CM, Camarda J, Fisher DJ, Millar A, McIntosh JF (2006b) Acute nicotine fails to alter event-related potential or behavioral performance indices of auditory distraction in cigarette smokers. Nicotine Tob Res 8:263–273 ArticlePubMedCAS Google Scholar
Kujala T, Tervaniemi M, Schroger E (2007) The mismatch negativity in cognitive and clinical neuroscience: Theoretical and methodological considerations. Biol Psychol 74:1–19 ArticlePubMed Google Scholar
Laruelle M, Kegeles LS, Abi-Dargham A (2003) Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci 1003:138–158 ArticlePubMedCAS Google Scholar
Liddle PF (2000) Cognitive impairment in schizophrenia: its impact on social functioning. Acta Psychiatr Scand, Suppl 400:11–16 ArticleCAS Google Scholar
Light GA, Braff DL (2005) Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry 62:127–136 ArticlePubMed Google Scholar
Luciana M, Depue RA, Arbisi P, Leon A (1992) Facilitation of working memory in humans by a D2 dopamine receptor agonist. J Cogn Neurosci 4:58–68 Article Google Scholar
Markham A, Benfield P (1997) Pergolide, A review of its pharamacology and therapeutic use in Parkinson’s disease. CNS Drugs 7:328–340 CAS Google Scholar
Mehta MA, Riedel WJ (2006) Dopaminergic enhancement of cognitive function. Curr Pharm Des 12:2487–2500 ArticlePubMedCAS Google Scholar
Michie PT, Budd TW, Todd J, Rock D, Wichmann H, Box J, Jablensky AV (2000) Duration and frequency mismatch negativity in schizophrenia. Clin Neurophysiol 111:1054–1065 ArticlePubMedCAS Google Scholar
Moore H, West AR, Grace AA (1999) The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry 46:40–55 ArticlePubMedCAS Google Scholar
Muller U, von Cramon DY, Pollmann S (1998) D1- versus D2-receptor modulation of visuospatial working memory in humans. J Neurosci 18:2720–2728 PubMedCAS Google Scholar
Näätänen R (1992) Attention and brain function. Erlbaum, Hillsdale, NJ Google Scholar
Näätänen R (2000) Mismatch negativity (MMN): perspectives for application. Int J Psychophysiol 37:3–10 ArticlePubMed Google Scholar
Näätänen R, Winkler I (1999) The concept of auditory stimulus representation in cognitive neuroscience. Psychol Bull 125:826–859 ArticlePubMed Google Scholar
Nakagome K, Ichikawa I, Kanno O, Akaho R, Suzuki M, Takazawa S, Watanabe H, Kazamatsuri H (1998) Overnight effects of triazolam on cognitive function: an event-related potentials study. Neuropsychobiology 38:232–240 ArticlePubMedCAS Google Scholar
Pang EW, Fowler B (1999) Dissociation of the mismatch negativity and processing negativity attentional waveforms with nitrous oxide. Psychophysiology 36:552–558 ArticlePubMedCAS Google Scholar
Pekkonen E (2000) Mismatch negativity in aging and in Alzheimer’s and Parkinson’s diseases. Audiol Neuro-Otol 5:216–224 ArticleCAS Google Scholar
Pekkonen E, Hirvonen J, Ahveninen J, Kähkönen S, Kaakkola S, Huttunen J, Jääskeläinen IP (2002) Memory-based comparison process not attenuated by Haloperidol: a combined MEG and EEG study. Neuroreport 13:177–181 Article Google Scholar
Rinne T, Alho K, Ilmoniemi RJ, Virtanene J, Näätänen R (2000) Separate time behaviors of the temporal and frontal mismatch negativity sources. Neuroimage 12:14–19 ArticlePubMedCAS Google Scholar
Rosburg T, Marinou V, Haueisen J, Smesny S, Sauer H (2004) Effects of lorazepam on the neuromagnetic mismatch negativity (MMNm) and auditory evoked field component N100m. Neuropsychopharmacology 29:1723–1733 ArticlePubMedCAS Google Scholar
Sato Y, Yabe H, Todd J, Michie P, Shinozaki N, Sutoh T, Hiruma T, Nashida T, Matsuoka T, Kaneko S (2003) Impairment in activation of a frontal attention-switch mechanism in schizophrenic patients. Biol Psychol 62:49–63 ArticlePubMed Google Scholar
Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124:57–73 ArticleCAS Google Scholar
Serra JM, Escera C, Sanchez-Turet M, Sanchez-Sastre J, Grau C (1996) The H1-receptor antagonist chlorpheniramine decreases the ending phase of the mismatch negativity of the human auditory event-related potentials. Neurosci Lett 203:77–80 ArticlePubMedCAS Google Scholar
Shelley AM, Ward PB, Catts SV, Michie PT, Andrews S, McConaghy N (1991) Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol Psychiatry 30:1059–1062 ArticlePubMedCAS Google Scholar
Sinkkonen J, Tervaniemi M (2000) Towards optimal recording and analysis of the mismatch negativity. Audiol Neuro-Otol 5:235–246 ArticleCAS Google Scholar
Smolnik R, Pietrowsky R, Fehm HL, Born J (1998) Enhanced selective attention after low-dose administration of the benzodiazepine antagonist flumazenil. J Clin Psychopharmacol 18:241–247 ArticlePubMedCAS Google Scholar
Todd J, Michie PT, Jablensky AV (2003) Association between reduced duration mismatch negativity (MMN) and raised temporal discrimination thresholds in schizophrenia. Clin Neurophysiol 114:2061–2070 ArticlePubMed Google Scholar
Trantham-Davidson H, Neely LC, Lavin A, Seamans JK (2004) Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci 24:10652–10659 ArticlePubMedCAS Google Scholar
Tzschentke TM (2001) Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63:241–320 ArticlePubMedCAS Google Scholar
Umbricht D, Krljes S (2005) Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 76:1–23 ArticlePubMed Google Scholar
Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC (2000) Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 57:1139–1147 ArticlePubMedCAS Google Scholar
Umbricht D, Koller R, Vollenweider FX, Schmid L (2002) Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry 51:400–406 ArticlePubMedCAS Google Scholar
Umbricht D, Vollenweider FX, Schmid L, Grübel C, Skrabo A, Huber T, Koller R (2003) Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology 28:170–181 ArticlePubMedCAS Google Scholar
Wu Y, Pearl SM, Zigmond MJ, Michael AC (2000) Inhibitory glutamatergic regulation of evoked dopamine release in striatum. Neuroscience 96:65–72 ArticlePubMedCAS Google Scholar